Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Postauthorization Safety Surveillance Study Of Patients Switching To ReFacto AF From ReFacto Or Other Factor VIII Products In Usual Care Settings

NCT00884390 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00884390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00884390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Postauthorization Safety Surveillance Study Of Patients Switching To ReFacto AF From ReFacto Or Other Factor VIII Products In Usual Care Settings
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2009
Completion date
March 31, 2013
Enrollment
208 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a